empty

Musculoskeletal & Joint Diseases

93 results found for: Musculoskeletal & joint diseases

Staffordshire pharmacies paid for OA pilot consultations

Around 40 pharmacies are taking part in an arthritis pilot in the Staffordshire area.

Biosimilars on the menu for moderate rheumatoid arthritis

NICE guidance previously recommended biologics only for severe RA.

A new approach to osteoarthritis and joint pain

When customers come to your pharmacy with joint pain associated with osteoarthritis or joint wear and tear, it may mean they have reached the point where their quality of life is being impacted.

MS charities 'disappointed' by NICE decision on new drug

Multiple sclerosis charities have expressed their disappointment at NICE’s decision not to recommend ozanimod for patients in England and Wales. 

NICE recommends new drug for relapsing MS

NICE has recommended the use of auto-injectable MS drug ofatumumab on the NHS. 

Topicals cash in on self care trend

Exercise induced injuries rocketed during lockdown. Here's the latest news, and some advice about backpacks...

Topical pain relief is a hot topic

Nearly 15 million people in the UK suffer from musculoskeletal pain. Many of them head to their local pharmacy...

£11.1m funding boost not enough for NI pharmacies, says CPNI chair

Pharmacies in Northern Ireland receive additional funding of £11.1m, but it's not enough claims CPNI

Winter Health: Congestion

Find out more about how to advise customers on congestion and make effective product recommendations. 

Wanna buy a smart watch?

Is the pharmacy profession capitalising on the opportunities provided by technology to improve healthcare and service delivery to patients?  Outsider doesn't think so.

Pancreatic cancer – the role of pharmacy

This short animation will highlight the crucial role of the pharmacy team in recognising symptoms of pancreatic cancer to aid early diagnosis and boost survival rates.

NI pharmacy “light years behind”, facing “indiscriminate” closures

The funding crisis facing the community pharmacy sector in Northern Ireland will cause widespread closures, CPNI has said

AYP Week 2018 focuses on medicines safety

Ask Your Pharmacist Week has kicked off, with pharmacies around the country providing information on medicines safety

Most expensive NHS drug comes off patent

Adalimumab (Humira; AbbVie) is a biological medicine used to treat conditions including rheumatoid arthritis and Crohn’s disease

Taking a customer-first approach

Every interaction you have at the counter matters. This video will help you to deliver a first-class service to all your customers.

Medicines supply a concern in no-deal Brexit scenario

With less than six months to go before the UK leaves the European Union, there are still major concerns around medicines supply in the event of a no-deal Brexit, the commons health committee heard last week

Going local for a change

NHS England’s announcement last month that seven pilot regions will test a framework for using pharmacy expertise to deliver improved patient outcomes from medicines, begs the question: can the community pharmacy sector step up for local development?

Time to be brave and bold

Chris Martin, Alliance Healthcare non-executive advisor, finds future prospects brought into sharp focus by celebrations closer to home

Lincolnshire leads way for NMS

Rolling annual totals for NMS just under 1m, as latest figures reveal Lincolnshire pharmacies lead way

Community pharmacy clinical audit published

NHS England has published the paperwork for the 2018-19 national community pharmacy clinical audit, which all contractors must complete by the end of the year

Previous 1 2 3 4 5 Next


This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to P3 Pharmacy's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.